Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2401
Intellia Therapeutics
NTLA
$1.72B
| $8.31M | ﹤0.01% |
491,226
+420,667
| +596% | +$5.89M |
2024 Q1
9 quarters
|
|
2402
PUT
Boston Scientific
BSX
$66.4B
| $8.3M | ﹤0.01% |
194,500
+28,700
| +17% | +$1.56M |
2018 Q2
32 quarters
|
|
2403
CALL
TJX Companies
TJX
$159B
| $8.29M | ﹤0.01% |
54,700
-109,300
| -67% | -$17.3M |
2022 Q3
15 quarters
|
|
2404
Ollie's Bargain Outlet
OLLI
$5.29B
| $8.29M | ﹤0.01% |
107,790
-598,211
| -85% | -$49.9M |
2024 Q1
9 quarters
|
|
2405
Duolingo
DUOL
$7.55B
| $8.28M | ﹤0.01% |
72,013
-259,371
| -78% | -$28.4M |
2021 Q4
18 quarters
|
|
2406
Rush Enterprises Class A
RUSHA
$5.17B
| $8.28M | ﹤0.01% |
170,147
-55,827
| -25% | -$2.63M |
2021 Q2
20 quarters
|
|
2407
Safeguard Acquisition Corp
SAC
$317M
| $8.27M | ﹤0.01% |
822,000
| – | – |
2026 Q1
1 quarter
|
|
2408
BCE
BCE
$19.2B
| $8.25M | ﹤0.01% |
383,687
-66,125
| -15% | -$1.59M |
2025 Q2
4 quarters
|
|
2409
KRAKacquisition Corp
KRAQ
$432M
| $8.25M | ﹤0.01% |
825,000
+525,000
| +175% | +$5.21M |
2026 Q1
1 quarter
|
|
2410
SunCoke Energy
SXC
$912M
| $8.24M | ﹤0.01% |
1,024,201
-624,648
| -38% | -$4.83M |
2022 Q2
16 quarters
|
|
2411
Patterson-UTI
PTEN
$4.06B
| $8.22M | ﹤0.01% |
895,701
-4,400,607
| -83% | -$49.1M |
2024 Q3
7 quarters
|
|
2412
Sibanye-Stillwater
SBSW
$6.64B
| $8.21M | ﹤0.01% |
967,328
+660,305
| +215% | +$7.7M |
2018 Q1
33 quarters
|
|
2413
Assembly Biosciences
ASMB
$406M
| $8.21M | ﹤0.01% |
298,807
+65,157
| +28% | +$1.77M |
2025 Q3
3 quarters
|
|
2414
UBS Group
UBS
$154B
| $8.2M | ﹤0.01% |
165,363
-339,181
| -67% | -$15.4M |
2024 Q4
6 quarters
|
|
2415
Inhibikase Therapeutics
IKT
$207M
| $8.18M | ﹤0.01% |
4,028,102
+1,100,025
| +38% | +$1.97M |
2025 Q4
2 quarters
|
|
2416
Happen Inc
HAPN
$1.8B
| $8.17M | ﹤0.01% |
394,048
-128,928
| -25% | -$2.2M |
2020 Q2
24 quarters
|
|
2417
Pyrophyte Acquisition Corp II
PAII
$282M
| $8.17M | ﹤0.01% |
801,000
| – | – |
2025 Q3
3 quarters
|
|
2418
RenaissanceRe
RNR
$14B
| $8.17M | ﹤0.01% |
25,773
-14,251
| -36% | -$4.28M |
2025 Q1
5 quarters
|
|
2419
PUT
Iron Mountain
IRM
$34.7B
| $8.16M | ﹤0.01% |
64,600
+55,000
| +573% | +$6.74M |
2023 Q1
13 quarters
|
|
2420
CALL
VeriSign
VRSN
$28.2B
| $8.15M | ﹤0.01% |
32,400
+16,700
| +106% | +$4.64M |
2025 Q1
5 quarters
|
|
2421
PUT
The Mosaic Company
MOS
$6.87B
| $8.15M | ﹤0.01% |
384,400
+74,900
| +24% | +$1.73M |
2021 Q2
20 quarters
|
|
2422
Utz Brands
UTZ
$1.27B
| $8.14M | ﹤0.01% |
1,056,928
-182,165
| -15% | -$1.36M |
2023 Q3
11 quarters
|
|
2423
Idacorp
IDA
$8.55B
| $8.12M | ﹤0.01% |
53,700
+28,633
| +114% | +$4.12M |
2022 Q3
15 quarters
|
|
2424
Vertical Aerospace
EVTL
$67.6M
| $8.12M | ﹤0.01% |
4,668,120
+2,303,196
| +97% | +$5.53M |
2023 Q3
11 quarters
|
|
2425
Genuine Parts
GPC
$17.1B
| $8.12M | ﹤0.01% |
68,831
-385,567
| -85% | -$40.2M |
2020 Q1
25 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.